Figure 2
Figure 2. Immunoprecipitation and immunoblot for VEGF receptors and PTK7. (A) Confluent MS1 cells were collected and lysed 2 hours after treatment with 20 ng/mL VEGF-A (control cells were not so treated). Immunoprecipitation was performed using 3 μg of antibodies specific for Flt-1, Flk-1/KDR, and Flt-4, and with 350-μg amounts of protein samples. Precipitates were collected and immunoblotting performed using antibodies against either PTK7 or VEGF receptors (**P < .01, compared with control). (B) Receptor complex formation between PTK7 and Flt-1 was assessed over time by immunoprecipitation and immunoblotting. MS1 cells, starved of serum and cytokines for 24 hours, were treated with 20 ng/mL VEGF-A and collected at various time points (5, 15, 30, 60, and 120 minutes). Immunoprecipitation and immunoblotting were performed as for panel A.

Immunoprecipitation and immunoblot for VEGF receptors and PTK7. (A) Confluent MS1 cells were collected and lysed 2 hours after treatment with 20 ng/mL VEGF-A (control cells were not so treated). Immunoprecipitation was performed using 3 μg of antibodies specific for Flt-1, Flk-1/KDR, and Flt-4, and with 350-μg amounts of protein samples. Precipitates were collected and immunoblotting performed using antibodies against either PTK7 or VEGF receptors (**P < .01, compared with control). (B) Receptor complex formation between PTK7 and Flt-1 was assessed over time by immunoprecipitation and immunoblotting. MS1 cells, starved of serum and cytokines for 24 hours, were treated with 20 ng/mL VEGF-A and collected at various time points (5, 15, 30, 60, and 120 minutes). Immunoprecipitation and immunoblotting were performed as for panel A.

Close Modal

or Create an Account

Close Modal
Close Modal